ClinicalTrials.govpublic full text
Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients
recurrent glioblastoma multiforme, malignant glioma, adult brain tumor, vorinostat, saha, bevacizumab, avastin, gbm, glioblastoma multiforme, brain tumor, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 909180
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.